✦ LIBER ✦

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited

✍ Scribed by Perez-Lloret, S.

Book ID: 120641987
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 428 KB
Category: Article
ISSN: 1351-5101
DOI: 10.1111/ene.12113

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apomorphine monotherapy in the treatment

Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients

✍ Alice J. Manson; Kirsten Turner; Andrew J. Lees 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

Continuous subcutaneous infusion of apomorphine is now increasingly recognized as an effective treatment for refractory off periods and peak-dose dyskinesias in Parkinson's disease. We have reviewed our experience with apomorphine infusions, after a strategy decision in 1995 based on emerging precli

LISURIDE INFUSION PUMP: A DEVICE FOR THE

LISURIDE INFUSION PUMP: A DEVICE FOR THE TREATMENT OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE

✍ Obeso, J.A.; Luquin, M.R.; Martinez-Lage, J.M. 📂 Article 📅 1986 🏛 The Lancet 🌐 English ⚖ 499 KB

2.254 Non-interventional study on subcut

2.254 Non-interventional study on subcutaneous apomorphine in the treatment of ON/OFF fluctuations in patients with Parkinson's disease – an interim analysis

✍ F. Sixel-Doering; G. Ebersbach; P. Odin; H. Klinke; H. Mittendorf; C. Trenkwalde 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A Double-Blind, Randomized, Placebo and

A Double-Blind, Randomized, Placebo and Active-Controlled Study of Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease

✍ Joaquim J. Ferreira; Olivier Rascol; Werner Poewe; Cristina Sampaio; José-Franci 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

Efficacy and safety of opicapone, a new

Efficacy and safety of opicapone, a new COMT-inhibitor, for the treatment of motor fluctuations in Parkinson's Disease patients: BIPARK-II study

✍ Lees, A.; Ferreira, J.J.; Costa, R.; Rocha, J.-F.; Oliveira, C.; Lopes, N.; Nune 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Levodopa/DDCI and entacapone is the pref

Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort

✍ P. Damier; F. Viallet; M. Ziegler; I. Bourdeix; K. Rerat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB